Target intelligence / Profile preview

Ewing sarcoma associated transcript 1 (EWSAT1)

Target
EWSAT1
Molecular classification
long intergenic non-coding RNA (lincRNA), non-protein coding RNA
01

Overview

Ewing sarcoma associated transcript 1 (EWSAT1) is a long intergenic non-protein coding RNA (lincRNA) gene located on human chromosome 15. It is specifically upregulated in Ewing sarcoma cells as a downstream target of the EWS-FLI1 fusion transcription factor and plays a critical role in gene repression and maintenance of the oncogenic phenotype in Ewing sarcoma. EWSAT1 functions primarily through interaction with chromatin modifiers and RNA-binding proteins such as HNRNPK, leading to repression of a subset of EWS-FLI1-downregulated genes and facilitating tumor cell proliferation and growth in vitro. Its expression is highly specific to Ewing sarcoma relative to other tumors, making it a candidate biomarker for this disease, but it is not considered a classical therapeutic target like a receptor, enzyme, or transporter. No approved drugs directly target EWSAT1, and its functional or therapeutic modulation remains an area of research interest

Other names
FLJ33768LINC00277NCRNA00277TMEM84long intergenic non-protein coding RNA 277testicular tissue protein Li 207transmembrane protein 84
02

Mechanism of action

acts as a non-coding RNA mediator of gene repression downstream of the EWS-FLI1 fusion transcription factor, interacts with RNA-binding proteins (e.g., HNRNPK) to modulate gene expression

03

Biological functions

gene repressionregulation of cell proliferationmodulation of oncogenicity in Ewing sarcoma
04

Disease associations

cancer (specifically Ewing sarcoma)implicated in osteosarcomanasopharyngeal carcinoma
05

Safety considerations

none directly reportedlncRNA modulation presents therapeutic delivery and off-target challenges (general to lncRNAs)
06

Biomarkers

potential biomarker for Ewing sarcomanot established for patient selection or therapeutic efficacy monitoring

Beyond the preview

Go deeper on Ewing sarcoma associated transcript 1 (EWSAT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ewing sarcoma associated transcript 1 (EWSAT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call